DLB R&D to Revenue
Dolby Laboratories Common Stock · R&D to Revenue
DLB R&D to Revenue
Latest reported21.56%period ending
DLB Quarterly R&D/Revenue (7.86% → 21.56%)
Latest values, visible window
High-resolution chart · PNG
DLB r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 21.5574% | |
| 16.0885% | |
| 19.9238% | |
| 21.9739% | |
| 20.9104% | |
| 16.6974% | |
| 18.6662% | |
| 22.5179% | |
| 22.679% | |
| 17.1438% | |
| 21.2416% | |
| 24.2379% | |
| 23.0238% | |
| 18.0773% | |
| 19.2433% | |
| 22.311% | |
| 21.7066% | |
| 20.1635% | |
| 19.5727% | |
| 21.7405% | |
| 21.6507% | |
| 20.5934% | |
| 16.3571% | |
| 22.7611% | |
| 24.1316% | |
| 17.0789% | |
| 19.7515% | |
| 20.1424% | |
| 19.9921% | |
| 17.3314% | |
| 19.3954% | |
| 25.1485% | |
| 28.1018% | |
| 19.8494% | |
| 18.8444% | |
| 23.8887% | |
| 19.5086% | |
| 21.8118% | |
| 21.6016% | |
| 25.4141% | |
| 19.8053% | |
| 18.9867% | |
| 22.1449% | |
| 21.8669% | |
| 19.6407% | |
| 20.813% | |
| 20.7456% | |
| 20.7445% | |
| 20.9474% | |
| 16.0801% | |
| 19.225% | |
| 19.1307% | |
| 20.7245% | |
| 16.8232% | |
| 17.9356% | |
| 16.8886% | |
| 16.8965% | |
| 13.1546% | |
| 14.0656% | |
| 13.5818% | |
| 15.5645% | |
| 11.3584% | |
| 11.671% | |
| 12.9131% | |
| 11.9482% | |
| 10.3722% | |
| 10.3067% | |
| 11.0321% | |
| 10.057% | |
| 7.9579% | |
| 8.6243% | |
| 10.4714% | |
| 9.9574% | |
| 9.1129% | |
| 9.2573% | |
| 9.6609% | |
| 9.9103% | |
| 8.4955% | |
| 8.4602% | |
| 9.755% | |
| 9.7256% | |
| 7.9858% | |
| 8.7251% | |
| 9.6523% | |
| 8.6409% | |
| 9.0951% | |
| 9.8371% | |
| 9.668% | |
| 8.1341% | |
| 7.2435% | |
| 7.5417% | |
| 8.5014% | |
| 9.0721% | |
| 8.128% | |
| 7.8609% |